Qtpair 200 Tablet contains Quetiapine 200mg, a second-generation atypical antipsychotic used for the treatment of schizophrenia, bipolar disorder, and major depressive episodes associated with bipolar disorder. It works by modulating neurotransmitters in the brain, improving mood, cognition, and reducing psychotic symptoms.
Belonging to the Neurology & Psychiatry segment, Quetiapine is widely prescribed by psychiatrists and neurologists for both acute and maintenance therapy. Its efficacy and safety profile make it a preferred choice in chronic psychiatric care.
The tablet also helps manage mood swings, agitation, and hallucinations in bipolar disorder, providing stable long-term symptom control. It is commonly used in both outpatient and inpatient psychiatric settings.
For PCD pharma franchise partners, distributors, and exporters, Qtpair 200 Tablet offers a high-demand, profitable opportunity. It is available for third-party manufacturing, institutional supply, bulk distribution, and private-label branding across India, ensuring consistent market demand.